ClinicalTrials.Veeva

Menu

AMP Step Wedge Trial (AMP SWT)

Johns Hopkins University logo

Johns Hopkins University

Status

Completed

Conditions

Disability
Immobility

Treatments

Other: AMP Implementation

Study type

Interventional

Funder types

Other

Identifiers

NCT05021679
IRB00270215

Details and patient eligibility

About

Annually, more than 35 million patients are hospitalized in the United States. Many of these will experience hospital-acquired loss of physical functioning due to a lack of mobility during their in-patient stay. Such loss includes difficulties performing basic activities, such as rising from a chair, toileting, or ambulating. This loss of function may increase hospital length of stay (LOS), nursing home placement, and decrease mobility and participation in community activities even years after hospitalization. Prevention of this hospital-acquired functional loss is critical. Even the sickest hospitalized patients (e.g., those in the intensive care unit [ICU]), can safely and feasibly benefit from early mobilization. In the non-ICU setting there is evidence that patient mobilization reduces LOS and hospital costs, while improving patient satisfaction and physical and psychological outcomes. The overall objective of this proposed project is to evaluate the implementation and impact of a transdisciplinary and multifaceted mobility program (Johns Hopkins Activity and Mobility Promotion - AMP) on clinical outcomes among hospitalized adults. In addition to clinical outcomes, we will identify barriers and facilitators to high-performance program adoption. Results of this project will provide critical new insights on the effectiveness of AMP and inform dissemination and implementation nationwide.

Enrollment

16,676 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All adult patients admitted to study hospital unit
  • Analysis will only include those with lengths of stay >=3 days

Exclusion criteria

  • Patients with active do-not-resuscitate (DNR) order
  • <18 years old

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

16,676 participants in 1 patient group

AMP Implementation
Experimental group
Treatment:
Other: AMP Implementation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems